DBV Technologies (DBVT) Non-Current Assets (2015 - 2026)

DBV Technologies (DBVT) posted quarterly Non-Current Assets of $21.3 million for Q2 2026, down 4.0% year-on-year from $22.2 million in Q2 2025, and up 8.12% on a QoQ basis from $19.7 million in Q1 2026.

DBV Technologies (DBVT) Non-Current Assets (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Non-Current Assets for 12 consecutive years, with $21.3 million the latest figure, recorded in Q2 2026.

  • Quarterly Non-Current Assets fell 4.0% year-over-year to $21.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $21.3 million (down 4.0% YoY) and the FY2025 annual result came in at $20.8 million, down 2.21% from the prior year.
  • Non-Current Assets advanced to $21.3 million in Q2 2026 per DBVT's latest filing, from $19.7 million in the prior quarter.
  • Over the last five years, Non-Current Assets for DBVT reached as high as $27.1 million in Q1 2022 and fell as low as $19.7 million in Q1 2026.
  • A 5-year average of $22.8 million and a median of $22.3 million in 2022 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Non-Current Assets slumped 63.11% — and 2024, when it advanced 18.44%.
  • Year by year, Non-Current Assets stood at $23.4 million in 2022, then increased by 2.67% to $24.1 million in 2023, then slipped by 11.63% to $21.3 million in 2024, then fell by 2.21% to $20.8 million in 2025, then climbed by 2.4% to $21.3 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $21.3 million, $19.7 million, and $20.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - 21.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 21.30 Mn
Mar 31, 2026 19.70 Mn
Dec 31, 2025 20.80 Mn
Sep 30, 2025 21.61 Mn
Jun 30, 2025 22.19 Mn
Mar 31, 2025 21.41 Mn
Dec 31, 2024 21.27 Mn
Sep 30, 2024 24.30 Mn
Jun 30, 2024 24.23 Mn
Mar 31, 2024 26.33 Mn
Dec 31, 2023 24.07 Mn
Sep 30, 2023 20.51 Mn
Jun 30, 2023 21.98 Mn
Mar 31, 2023 22.69 Mn
Dec 31, 2022 23.44 Mn
Sep 30, 2022 22.42 Mn
Jun 30, 2022 25.03 Mn
Mar 31, 2022 27.14 Mn
Dec 31, 2021 32.34 Mn
Sep 30, 2021 60.79 Mn